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functional tasks resembling conditions of daily life (ADL). 20 subjects
(39%) were not able to perform all hop tests, mainly due to hesitation or
for safety reasons (close to surgery). No difference was observed in knee
position score between men and women for any of the functional tasks.
Whenmen and womenwere pooled, no correlationwas found between
TDPM and knee position for the ADL tasks. Poorer TDPMwas associated
with a knee medial to foot position during the drop jump (rs ¼ 0.409, P
¼ 0.013). No relation was found between VPT at MTP1, MM or MF and
medio-lateral knee position in the pooled group. When women were
analyzed separately, no relation was found between TDPM and knee
position for the ADL tasks. For the hop tests, poorer TDPM was asso-
ciated with a knee medial to foot position during drop jump (rs¼ 0.469,
P ¼ 0.106) and cross over hop (rs ¼ 0.697, P ¼ 0.012). Worse vibration
sense was associated with a knee medial to foot position for stair
descending, stair ascending and forward lunge, (rs ¼ 0.467–0.606, P ¼
<0.025). No association was found between VPT and knee position for
the hop tests. In men, there were no relations between TDPM and knee
position for the ADL tasks. Poorer TDPM was associated with a knee
medial to foot position during drop jump (rs ¼ 0.423, P ¼ <0.044). No
relation was found between VPT at MTP1, MM or MF and medio-lateral
knee position in men (Table 1).
Conclusions: Worse kinesthetic acuity seems to be low to moderately
associated with worse movement quality, determined as a knee medial
to foot position, during hop tests. Poor vibration sense at the foot, seems
to be related to a knee medial to foot position during several different
functional tasks in women, whereas no such association seems to be
present in men.
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Purpose: Recent evidence suggests that bone marrow lesions (BMLs) of
the tibia and femur predict local cartilage loss and play an important
role in knee pain; but it remains unclear whether patellar BMLs have
similar roles. Aim of this study was to examine whether patellar BMLs
are associated with cartilage loss (defects and/or volume loss) and knee
pain in older adults.
Methods: A total of 904 randomly selected subjects (mean 62.4 years,
49.9% female) were studied. OARSI atlas was used to assess radiographic
knee osteophytes and joint space narrowing (JSN). T1- or T2-weighted
fat suppressed magnetic resonance imaging (MRI) was used to assess
bone marrow lesions (BMLs), cartilage volume and cartilage defects.
Knee pain was assessed by self-administered Western Ontario
McMaster Osteoarthritis Index (WOMAC) questionnaire.
Results: The prevalence of any patellar BMLs was 18.8%. Cross-sec-
tionally, patellar BMLs were positively associated with any BMLs at
tibiofemoral compartments (OR: 2.52, 95% CI: 1.78, 3.56), medial and
lateral femoral cartilage defects, patellar cartilage defects (OR: 12.99,
95% CI: 8.28, 20.39), and any knee painwhen going up/down stairs (OR:
1.67, 95% CI: 1.18, 2.35), but negatively associated with patellar cartilage
volume (b: 345.7 mm3, 95% CI: 470.9, 220.4) after adjustments of
age, sex, BMI, and rheumatoid arthritis. Longitudinally, baseline patellar
BMLs was associated with increases in any BMLs in tibiofemoral com-
partment (OR: 2.21, 95% CI: 1.27, 3.85), increases in patellar cartilage
defects (OR: 1.75, 95% CI: 1.01, 3.05) and an increase in knee pain when
go up/down stairs (OR: 1.67, 95% CI: 1.08, 2.59) over 2.6 years in mul-
tivariable analyses. Baseline patellar BMLs were negatively associated
with changes in cartilage volume at patellar (b: 2.10%, 95% CI: 3.39%,
0.80%), medial tibial (b: 1.36%, CI: 2.70%, 0.02%) and lateral tibial
(1.21%, 3.39%, 0.80%) sites. The associations with changes in tibialcartilage volume became non-signiﬁcant after further adjustment for
baseline tibial BMLs.
Conclusions: Patellar BMLs were consistently associated with increases
in patellar cartilage defects, loss of patellar cartilage volume and knee
pain when going up/down stairs, suggesting a local effect of patellar
BMLs in the developmnt and progression of patellofemoral OA.
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Purpose: In the large majority of patients with severe hip and knee
osteoarthritis (OA) pain, physical functioning and quality of life improve
signiﬁcantly after total hip arthroplasty (THA) or total knee arthroplasty
(TKA). In a subgroup of patients the outcomes are however less favor-
able, with comorbidity, amongst others, being identiﬁed as one of the
contributing factors. Therefore the aim of this study was to describe the
presence of comorbidities and the associations of the number of
comorbidities, and speciﬁc comorbidities with pain, physical function-
ing and quality of life in osteoarthritis patients with who underwent
THA or TKA.
Methods: In this cross-sectional study 521 patients with hip or knee OA
who underwent THA or TKA in the previous 5–22 months were
recruited from 4 hospitals (281 THA and 240 TKA). Sociodemographic
characteristics, information on comorbidities (19-item questionnaire),
pain and physical functioning (subscores of the Hip disability Osteo-
arthritis Outcome Score (HOOS), and the Knee injury Osteoarthritis
Outcome Score (KOOS)), and quality of life (SF 36 physical and mental
component scores) were collected by means of a paper questionnaire.
Statistical analysis included descriptive statistics and multivariate
regression analysis.
Results: Characteristics of participating OA patients in this survey were:
female 65.2%, mean age 70.0 (SD 9.3) years, mean BMI 27.8 (SD 4.7),
mean pain score 81.7 (SD 19.1), mean physical functioning score 78.9
(SD 20.9), and a mean quality of life physical and mental component
score of respectively 45.4 (SD 8.6) and 47.7 (SD 7.7). BMI was sig-
niﬁcantly higher, and pain and physical functioning scores were sig-
niﬁcantly worse for TKA patients compared to THA. Overall 86% of the
patients had one ormore comorbidities. The proportion of patients with
5 or more comorbidities was higher in patients with TKA as compared
to THA (47 (19.6%) and 37 (13.2%) respectively (p ¼ 0.047)). Concerning
the presence of individual comorbidities, hypertension and hearing
impairments in a group conversation were the most frequently repor-
ted comorbidities (>25% for the total group). Severe back pain, severe
neck/shoulder pain, severe elbow, wrist or hand pain, cancer and
malignant diseases, incontinence of urine, and vision impairment in
short distances were reported by 15–25% of the patients in the total
group. In both THA and TKA severe back pain (reported in 19%) and
dizziness in combination with falling (reported in 6%) were most
commonly associated with all four outcomes. Reported comorbidities
were more associated with worse outcome in physical functioning and
quality of life than with worse pain. Poor outcome increases with
number of comorbidities, and in patients with 5 or more comorbidities
associations were seen with all outcomes. Factors in the best ﬁt asso-
ciation model for the total group of patients with THA and TKA for the
different outcomes are: Dizziness in combination with falling, severe
back pain, cancer and malignant diseases, and BMI for HOOS/KOOS
subscale pain; Dizziness in combination with falling, vision impair-
ments in long distances, severe back pain, severe neck/ shoulder pain,
and BMI for HOOS/KOOS subscale physical functioning; incontinence of
urine, severe back pain, sex, severe neck/ shoulder pain, BMI, and age
for the SF36 physical component scale; dizziness in combination with
falling, (consequences) of stroke, migraine , and incontinence of urine
for the SF36 mental component scale.
Conclusions: Various comorbidities, different in THA and TKA were
associated with outcome, especially with physical functioning and the
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S186physical component of quality of life. Particularly severe back pain and
dizziness in combination with falling, and 5 or more comorbidities
should be taken into account in OA patients undergoing joint replace-
ment surgery, in order to tune to expectations, satisfaction and outcome
after surgery.
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Purpose: Joint replacement is a common operation, predominantly
provided to older adults with osteoarthritis. Reduced function is one of
themain indications for joint replacement, and recovery of function one
of its main objectives. Adequate assessment of function is critical to help
both health care professionals and patients decide upon treatment
options and to enable evaluation of the effectiveness of joint
replacement.
Physical function is commonly assessed in three ways: patient-reported
outcome measures (PROMs), performance tests, and clinician-admin-
istered measures. It is recommended that several types of these
measures should be used concurrently to capture an extended picture
of function but patient burden, resources and logistical constraints
mean that such an approach is seldom feasible. Moreover, most of the
tools in use do not clearly differentiate between impairments, activity
limitations and participation restrictions, and it is unclear to what
extent each measure describes them, which in turn has implications as
to their substitutability and comparability. The picture is further com-
plicated by the effects of multi-morbidity and patient characteristics on
functional measures.
The aims of this research were twofold: 1) to describe the correlations
between a variety of commonly used functional measures collected on
the same group of older patients listed for hip or knee replacement, and
2) explore associations between these measures and patient
characteristics.
Methods: 1,451 patients listed for primary or revision hip or knee
replacement at a single high-volume orthopaedic centrewere invited to
take part in a study of function before joint replacement. 264 agreed to
do so and provided their informed consent.
Participants were asked to complete a postal questionnaire about their
age, gender, BMI, living arrangements, education level and working
status. They completed the Functional Co-morbidity Index and the
Hospital Anxiety and Depression Scale. The severity of arthritis was
derived as a count of affected joints other than the joint listed for sur-
gery. Two PROMs were also completed, the Western Ontario McMaster
Arthritis Index pain and function scales and the Aberdeen Impairment,
Activity Limitation and Participation measure.
Participants were also invited to an appointment during which clini-
cian-administered measures and performance tests were performed.
These comprised the Harris Hip Score (HHS) or the American Knee
Society Score (AKSS), which were completed by a research nurse. The
performance tests were a timed 20 metre walk, the get-up-and-go test,
step tests (20 and 30 cm high blocks), and a single stance balance test.
The relationships between the functional measures were assessed with
Spearman Rank coefﬁcient, point-biserial coefﬁcient or Cramer’s V
statistic. The association between participants’ characteristics and
functional measures were investigated with linear regression or
modiﬁed Poisson regression with robust error variance. Individual
patient characteristics were ﬁrst considered in univariate models and
then in multivariate analyses to determine if their effects were con-
founded by other factors. The analyses were conducted separately for
hip and knee patients.
Results: Strong to moderate correlations were found within PROMs (r
¼ 0.63 to 0.88) and within performance tests, but correlations were
weaker between these two assessment approaches (r ¼ 0.17 to 0.65).
The HHS correlated better with PROMs (r w0.70) than performance
tests (r¼ 0.38 to 0.67); poor correlations were foundwith the AKSS and
other functional measures (r ¼ 0.18 to 0.28).Patients’ psychological well-being was associated with PROMs (p-value
<0.0001) but not with performance tests. Age was associated with
performance tests (p-values ranging from <0.05 to <0.0001) but not
with PROMs. Pain was strongly associated with function irrespectively
of the measurement method. Other patient characteristics had weak or
no association with function.
Conclusions: We found that PROMs, performance tests and clinician-
administered measures provide information on different aspects of
function. This study also shows that associations between function and
patient characteristics differed according to the measurement approach
used. The functional limitations caused by joint pathology are entan-
gled with the limitations resulting from ageing when measured with
performance tests; while psychological status seems to play an
important role in patients’ self-reported perception of functional ability.
Both objective and subjective measures need to be adjusted for pain to
enable appropriate interpretation.
318
CLINIMETRICS OF THE STAIR CLIMB TEST IN THE AMSTERDAM
COHORT
J.H. Abbott y, M. van der Esch z, L.D. Roorde z, J. Knoop z,
M. van der Leeden z, W.F. Lems z. yUniv. of Otago, Dunedin, New Zealand;
zAmsterdam Rehabilitation Res. Ctr., Reade, Amsterdam, Netherlands
Purpose: OARSI recently published recommendations for physical
performance tests in hip or knee osteoarthritis (OA). A test of stair
climbing was recommended, but the authors could not recommend a
speciﬁc stair climbing test or report clinimetric properties due to a lack
of data in the literature. The purpose of this study was to describe
clinimetric properties of the stair climb test (SCT) in people with knee
OA. SCT-up and SCT-down were reported separately, to reveal poten-
tially differing clinimetric properties.
Methods: Baseline and 2-year follow-up data from the Amsterdam
Cohort (n ¼ 200) were analyzed. Construct validity (convergent) was
estimated using Pearson’s correlation coefﬁcients between the SCTs and
the Western Ontario and McMaster Osteoarthritis index (WOMAC).
Smallest detectable change (SDC) at the 90% conﬁdence level was cal-
culated from the standard error of measurement (SEM). We report the
difference in SCT means between responders and non-responders at
different cut-points of WOMAC Total scale score (WOMAC-T); WOMAC
physical function subscale score (WOMAC-PF); and knee extensor
strength change reported in the literature. Minimum important change
(MIC) was calculated using receiver operating characteristics (ROC)
curve methodology, from baseline and follow-up data. The change data
was dichotomised into responders and non-responders using cut-off
criteria for each of the following external references: WOMAC-T;
WOMAC-PF; and knee extensor strength change. MIC estimates for
small, medium and large change are reported for each of the cut-points
sourced from the literature. Construct validity (discriminant) was esti-
mated using the area under the ROC curve (AUC), with an a priori sig-
niﬁcance level of .80.
Results: Construct validity (convergent) was moderate (.39) against
WOMAC-T and WOMAC-PF (.41). SDC (90%) was larger for SCT-down
(3.75 sec) than for SCT-up (1.63 sec). The proportion of patients
achieving MCID on the WOMAC-T was 44.5% and for small change
and 33.5% for moderate change. For WOMAC-T, the difference in
mean SCT time for those who achieved small change in SCT-up was
.82 sec (95%CI .27, 1.4) and .93 sec (.35, 1.5) for moderate change.
The difference in SCT-up means between responders and non-res-
ponders on the WOMAC-PF were .87 (.27, 1.50), .89 (.08, 1.38) and
.74 (.09, 1.38) for small, moderate and large changes, respectively. For
knee extensor strength, the differences in SCT-up means were: .46
(.08, .99), .43 (.15, 1.01), .36 (.31, 1.03), and .09 (.66, .84) for
small, moderate, medium and large changes respectively. MIC for the
SCT-up was .40 for small change and 0.70 for moderate change in
WOMAC-T. MIC for the SCT-up based on small, moderate and large
changes in WOMAC-PF were .40, .40 and .30, respectively. MIC
for the SCT-up based on small, moderate, medium and large changes
in knee extensor strength was .70 at all levels. MDC and MIC
values for the SCT-down were larger or equal in 7 of 9 analyses. AUC
values did not exceed .75 for any ROC analysis.
